Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 20;5(4):e724.
doi: 10.1002/hsr2.724. eCollection 2022 Jul.

Bacterial diversity significantly reduces toward the late stages among filarial lymphedema patients in the Ahanta West District of Ghana: A cross-sectional study

Affiliations

Bacterial diversity significantly reduces toward the late stages among filarial lymphedema patients in the Ahanta West District of Ghana: A cross-sectional study

Samuel O Asiedu et al. Health Sci Rep. .

Abstract

Background: Lymphatic Filariasis (LF), a neglected tropical disease, has been speculated to be complicated by secondary bacteria, yet a systematic documentation of these bacterial populations is lacking. Thus, the primary focus of this study was to profile bacteria diversity in the progression of filarial lymphedema among LF individuals with or without wounds.

Methods: A cross-sectional study design recruited 132 LF individuals presenting with lymphedema with or without wounds from eight communities in the Ahanta West District in the Western Region, Ghana. Swabs from the lymphedematous limbs, ulcers, pus, and cutaneous surfaces were cultured using standard culture-based techniques. The culture isolates were subsequently profiled using Matrix-assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry.

Results: Of the 132 LF participants recruited, 65% (85) had filarial lymphedema with no wounds. In total, 84% (235) of the bacterial isolates were identified. The remaining 16% (46) could not be identified with the method employed. Additionally, 129(55%) of the strains belonged to the phylum Firmicutes, while 61 (26%) and 45 (19%) represented Proteobacteria and Actinobacteria, respectively. Generally, irrespective of the samples type (i.e., wound sample and non-wound samples), there was a sharp increase of bacteria diversity from Stages 1 to 3 and a drastic decrease in these numbers by Stage 4, followed by another surge and a gradual decline in the advanced stages of the disease. The Shannon Diversity Index and Equitability for participants with and without wounds were (3.482, 0.94) and (3.023, 0.75), respectively. Further, Staphylococcus haemolyticus and Escherichia coli showed resistance to tetracycline, chloramphenicol, and penicillin.

Conclusion: The present study reveals a sharp decline in bacterial load at the late stages of filarial lymphedema patients. In addition, we report an emerging antimicrobial resistance trend of S. haemolyticus and E. coli against commonly used antibiotics such as tetracycline, chloramphenicol, and penicillin in communities endemic for LF in the Ahanta West District, Ghana. This could pose a huge challenge to the management of the disease; particularly as current treatments are not quite effective against the infection.

Keywords: MALDI‐TOF; antimicrobial resistance; lymphatic filariasis; lymphedema; microbiome.

PubMed Disclaimer

Conflict of interest statement

All authors have read and approved the final version of the manuscript. Alexander Kwarteng (EDCTP‐TMA2016 1561) had full access to all the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.

Figures

Figure 1
Figure 1
A geographical map of the study communities
Figure 2
Figure 2
The leg staging of lymphedema presented by study participants (Leg staging according to ref. [25]
Figure 3
Figure 3
A Venn diagram of bacterial communities in the wound and non‐wound samples
Figure 4
Figure 4
The profile of bacteria isolates among the female study participants
Figure 5
Figure 5
The profile of bacteria isolates among the male study participants
Figure 6
Figure 6
The bacterium types in the non‐wound and wound sample types
Figure 7
Figure 7
The dynamics of bacteria numbers among study participants
Figure 8
Figure 8
The phylum distribution in the study communities
Figure 9
Figure 9
The resistance profile of prominent Gram‐positive bacteria in wound samples
Figure 10
Figure 10
The resistance profile of prominent Gram‐negative bacteria in wound samples
Figure 11
Figure 11
The resistance profile of prominent Gram‐positive bacteria in non‐samples
Figure 12
Figure 12
The resistance profile of prominent Gram‐negative bacteria in non‐wound sample

Similar articles

Cited by

References

    1. Ellis SR, Nguyen M, Vaughn AR, et al. The skin and gut microbiome and its role in common dermatologic conditions. Microorganisms. 2019;7:1‐19. - PMC - PubMed
    1. Balato A, Cacciapuoti S, Di Caprio R, et al. Human microbiome: composition and role in inflammatory skin diseases. Arch Immunol Ther Exp. 2019;67:1‐18. - PubMed
    1. Schommer NN, Gallo RL. Structure and function of the human skin microbiome. Trends Microbiol. 2013;21:660‐668. - PMC - PubMed
    1. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369‐2379. - PubMed
    1. Integrative HMP (iHMP) Research Network Consortium . The Integrative Human Microbiome Project. Nature. 2019;569:641‐648. - PMC - PubMed

LinkOut - more resources